The longitudinal relationship between immune cell profiles and frailty in patients with breast cancer receiving chemotherapy

BACKGROUND: Frailty is associated with an increased risk of chemotherapy toxicity. Cellular markers of inflammation can help identify patients with frailty characteristics. However, the role of cellular markers of inflammation in identifying patients at risk of developing chemotherapy-induced frailt...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Breast Cancer Res
Autors principals: Gilmore, Nikesha, Mohile, Supriya, Lei, Lianlian, Culakova, Eva, Mohamed, Mostafa, Magnuson, Allison, Loh, Kah Poh, Maggiore, Ronald, Belcher, Elizabeth, Conlin, Alison, Weiselberg, Lora, Ontko, Mary, Janelsins, Michelle
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7863416/
https://ncbi.nlm.nih.gov/pubmed/33546731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-021-01388-w
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars